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Abstract

Introduction

To better understand urinary inhibitors of calcium
oxalate crystallization, both z.eta potential measurement
and particle siz.e analysis were chosen to illustrate: (1)
the potential therapeutic efficacy of G872, a semi-synthetic sulfated polysaccharide, in stone prevention; and
(2) the relative contribution of various urinary fractions
{e.g., ultrafiltered urine (UFU), Tamm-Horsfall protein
(THP), urinary polyanionsprecipitated with cetylpyridinium chloride (CPC), urinary macromolecular substances
with different concentration ratios (UMSl0,50,90 and
UMS'l0,50,90) and THP-free urine (THPFU)} to total
urinary inhibitory activity. The results showed: (1) addition of G872 significantly enhances urinary inhibitory
activity and negative z.eta potential values; (2) re-addition of the CPC to UFU completely restores urinary inhibitory activity; and (3) artificial urines prepared by
mixing UMS' 10,50,90 from THPFU with UFU differed
in inhibitory activity from that prepared by mixing
UMSl0,50,90 from a pooled normal urine with UFU.
Based on these experimental results, the following speculations can be made: (1) normal human urines are considered to be a protective colloidal system; (2) urinary
inhibitory activity originates mainly from CPC and/or
UMS; (3) normal THP is a protective material to maintain urinary inhibitory activity; and (4) mutual interaction between urinary inhibitors may change the total urinary inhibitory activity.

From a physico-chemical viewpoint the main factors
dealing with renal stone formation in the overall urinary
tract can be summariz.ed in eq. (1) [11],

4> = 4> (X, Y, Z)

(1)

where 4> is the function describing a risk tendency for
suffering from stone disease. Three variables are involved in this function which may determine the stone
formation risk of an individual: X, the supersaturation of
stone salts in urine (a thermodynamic parameter); Y, the
urinary inhibitory activity against stone salts crystallization (a kinetic parameter); and Z, the crystal retention to
urinary-tract epithelium cells (a colloid and interfacial
chemical parameter).
In the past decade, the early events of stone formation as well as the roles of renal tubule cells in nephrolithiasis have been emphasiz.ed [24]. For the situation inside a nephron, a equation, similar to eq. (1), can be
formulated {eq. (2)},

4> = 4> (x, y, z)

(2)

where 4> has the same meaning as in eq. (1). Three variables (x, y, z) associate to early events of stone formation occurring within the kidney. They are the renal
handling of stone salt ions (x), synthesis/secretion of
modifiers of stone salts crystallization (y) and cell-crystal
interaction (z). Comparing eq. (2) to eq. (1), one may
find the corresponding relationship between the two theories of stone formation (X, Y, Z versus x, y, z).
Current opinion seems more and more to emphasiz.e the
importance of cellular and molecular levels [6].
It has been known that different behaviors of stone
salt crystallization inside a nephron are associated with
the properties of the interfaces between crystals and their
surrounding liquids and between renal epithelial cells
and their surroundings. Since the additivity of urinary
inhibitors exists only in the mass, but not in their functions {eqs. (3) and (4)}, the following two factors should
be considered: (1) the urinary environment such as urinary components, pH, ionic strength and supersaturation
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Table 1. Artificial urine composition (A:B = 1: 1).

mental conditions depending on pH, ionic strength, calcium and citrate [17, 18, 20, 25]; (2) the same kind of
material, but with a different molecular weight or existing state in solution, shows a different behavior to inhibition or promotion in calcium phosphate crystallization
under identical experimental conditions [23]; and (3) a
mixture of two different kinds of macromolecular inhibitor does not demonstrate a total inhibitory activity equal
to the sum of their individual capacities (our unpublished
data). These phenomena suggest that binding of urinary
small or macromolecular inhibitors on stone salts crystals could determine their functions in stone salts crystallization.
In the present study, a modification of the zeta potential measurement is introduced. Three urinary parameters: inhibitory activity against calcium oxalate
monohydrate (COM) crystal growth (IG) and agglomeration (IA), and zeta potential (ZP) have been chosen as
markers to evaluate urinary inhibitor properties. Urine
samples were collected from 10 stone-formers (SF) and
10 non-stone-formers (NSF) to define their inhibitory activity and ZP values in the presence and absence of
G872. After the measurements, all NSF urines were
pooled (pooled normal urine, PNU) for preparation of
various urinary fractions including ultrafiltered urine
(UFU) , THP, THP-free urine (THPFU), urinary polyanions (CPC), as well as urinary macromolecular substances obtained form the whole urine (UMS) and from
THPFU (UMS'). UMS and UMS' were tested at several concentrations: 10, 50 and 90 %.
To better understand urinary inhibitors of calcium
oxalate crystallization, the inhibitory activity of the
pooled urines as well as their fractions has been studied.
Special attentions will be paid to answer: (1) whether a
exogenous semi-synthetic sulphated polysaccharide such
as G872 may significantly enhance urinary inhibitory activity? (2) which urinary components contribute most to
total urinary inhibitory activity? (3) what are characteristics of urinary inhibitors in human? and (4) what are the
factors that may influence urinary inhibitory activity?

A: solution
Salt

g/1

CaCl2·2H2O

1.765

NaiSO 4

4.862

MgSO 4 -7H2O

1.460

NH4 CL

4.643

KCl

12.133

B: solution
Salt

g/1

NaH2PO 4 ·2H2O
NaiHPO 4

6.800

Na3Citrate·2H2O

1.168

NaCl

13.51

0.869

o/

0.166

NaiC2

ionic strength = 0.33;

pH= 6. 10;

relative supersaturation of calcium oxalate = 1.29;
•sodium oxalate was excluded from actual applied
solution in this study.
may have an influence on the inhibitory activity of a
given urinary inhibitor; and (2) the interaction between
two given inhibitors may have an influence on the total
urinary inhibitory activity.
m

le

MTotal = ~ M(LM)i + ~ M(SM\
I

le

!Total

(3)

I

-;rt. ~
I

I(LM)i +

m
~

I(SM)j

(4)

I

in which MTotal is the total mass of inhibitors in a given
urine; E M(LM)i is the total mass of various macromolecular inhibitors in the urine (i = 1.. .k); E M(SM)j
is the total mass of various small molecular inhibitors in
the urine (j = 1...m). Whereas !Total is the total urinary
inhibitory activity, E I(LM)i is the total contribution of
i kind of macromolecular substances (LM) to the inhibitory activity (i = 1.. .k), and E I(SM)j is the total contribution of j kind of small molecular substances (SM) to
the inhibitory activity (j = 1.. .m).
Supportive findings have been reported: (1) A given
macromolecular substance such as Tamm-Horsfall protein (THP) shows a dual effect (inhibition and promotion) on stone salt crystallization under different experi-

Materials and Methods
Zeta potential measurement
The principle and method of ZP measurement has
been described elsewhere [2, 5]. In this study, a methodological modification was made. COM crystals were
first incubated with whole urine, and the crystals coated
by urinary inhibitors were washed and re-suspended to
an artificial urine. The procedure can be described as
follows: 1 ml urine sample was mixed with 50 µl of the
COM seed crystal suspension (24 mg/ml). After incubation of the mixtures at 37°C with shaking for 2 hours,
the crystals were collected by centrifugation and washed
402
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Figure 1. A schematic diagram of the preparations of urinary fractions from a pooled normal urine (PNU), the
meaning of various symbols is: CPC: urinary polyanions precipitated with cetylpyridinium chloride; THP: TammHorsfall protein isolated by adsorption with diatomaceous earth; THPFU: THP-free urine prepared by using the filter
procedure with the earth; UMS or UMS': Urinary macromolecular substances prepared from original PNU or THPFU
by using the ultrafiltration procedure; UFU: ultrafiltered urine; and MU/MU' 10,50,90: mimic urines. These mimic
urines were prepared by mixing of urinary macromolecular substances (UMS/UMS' 10,50,90) with UFU, according to
a given UFU to UMS/UMS' ratio's in volume. It should be noted that the composition of all mimic urines should be
the same as corresponding to their original urines (PNU or THPFU).

two times with a solution saturated with calcium oxalate.
The collected and washed COM crystals were re-suspended into 3 ml of 5 times diluted artificial urine (composition listed in Table 1). The mean ZP and ZP distribution of the COM crystals coated by urinary inhibitors
were measured using the Coulter DELSA 440 (Coulter
Electronics Ltd., Luton, U.K.).
To illustrate the effect of an addition of G872 to
urine on the COM zeta potential, the same procedure
was applied with addition of G872 (5 mg/1) to each urine
tested. The method was also used in mimic urines prepared by mixing the UFU with urinary fractions such as
THP, UMS, CPC and G872.

27] was chosen to address the inhibitory activity of
crystal growth and agglomeration for a given urine and
urinary fractions as well as other additives.

Urinary fraction preparation
The fresh morning urines (8:00-12:00 a.m.) were
collected without preservative from 10 patients with calcium oxalate nephrolithiasis and 10 normal subjects.
For determination of urinary inhibitory activity and ZP,
5 ml urines from each samples were centrifuged at 1500
g for 10 minutes and stored at -20°C until used. Remaining large volume urines of each sample were store
at 4°C. The individual 10 normal urines were pooled
and divided into three portions which were subjected to
several procedures as described in Figure 1. Urinary
GAGs concentration of the PNU was determined with
dimethylmethylene blue-based spectrophotometry [10).
(a) The first portion of the PNU (100 ml) was ultra-

Inhibitory activity measurement
A COM seeded crystal growth system based on particle size determination (Coulter Multisizer II) together
with a mathematical model as described by Ryall [26,
403
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IA(%)

IG (%)

100

80

ZP (-mV)

utes. The earth suspension was centrifuged at 20,000 g
for 20 minutes and the supernatant containing THP was
dialyzed against water and lyophilized. It has been
shown that the majority of THP present in urine can be
removed following this procedure.
The same procedure as described in (a) was applied
to 100 ml of the THPFU to acquire UMS without THP.
A second (THP-free) series of urinary macromolecular
substances (UMS' 10, UMS'50 and UMS'90) is obtained
according to the ultrafiltration procedure.
(c) The third portion of PNU (50 ml) and 50 ml
THPFU obtained from (b) were used to prepare urinary
polyanions (CPC). Briefly, 1 ml 5 % cetylpyridinium
chloride (Sigma) was mixed with 50 ml urine (PNU or
THPFU) and incubated overnight at 4 °C. After centrifugation at 10,000 g for 10 minutes, the obtained pellet,
CPC, was washed twice with absolute ethanol, dried and
dissolved in 2 M LiCI solution. After other centrifugation, the supernatant was mixed with ethanol to final
concentration of 90 %. Following storage of the mixture
at 4 °C for 48 hours, the final CPC was dissolved in
deionized water. The concentration of the CPC was
defined according to de Jong et al. [10].
Thus, the original PNU and THPFU as well as four
isolated fractions including UFU, THP, CPC and urinary macromolecular substances (UMSl0,50,90 and
UMS' 10,50,90) were obtained. From these fractions, a
series of mimic urines (MU' 10,50,90 and MUl0,50,90)
were reconstructed by adding UMS to UFU in the mentioned ratio in volume. The preparation procedures are
summarized in Figure 1.
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Figure 2. Scatter diagrams of data: (a) inhibitory
activity of COM crystal agglomeration (IA%) in stone
formers (SF) and non-stone formers (NSF) as well as
the alterations of the inhibitory activity after addition of
G872 (5 mg/I) to corresponding urines (bold line and
box); (b) inhibitory activity of COM crystal growth
(JG%); and (c) negative zeta potential values (ZP). The
central box covers the middle 50 % of the data values,
between the upper and lower quartiles. The "whiskers"
extend to the minimum and maximum values, and the
central line is at the median. Extreme values are plotted
as separate points useful for detecting outlier and
asymmetric behaviour. NS: no statistical significance;
*: statistically significant, p < 0.001).
filtered through a membrane with a 5 K.Da M .W. cutoff
(catalogue no. 887856, Spectrum Medical Industries,
Inc., Los Angeles, CA) to give an UFU and urinary
macromolecular substance. During the ultrafiltration,
the PNU was concentrated. Two milliliters of the concentrated urines were respectively collected at the following concentration ratio: 10 %, 50 % and 90 %, which
were respectively named as urinary macromolecular substances (UMSlO, UMS50 and UMS90). The remaining
UFU was kept as medium and stored at 4 °C.
(b) The second portion (500 ml) was used to isolate
THP and to prepare THPFU according to Serafini-Cessi
and associates [30] . Briefly, 5 g of diatomaceous earth
(Sigma, St. Louis, MO) suspended in deionized water
was poured into Buchner funnels of 70 mm in diameter
(Sigma-Aldrich Techware, Bornem, Belgium), lined with
No. 1 Whatman filter paper. The layer of diatomaceous
earth is washed first with deionized water and then with
0.025 M PBS (phosphate buffered saline) of pH 7.5,
containing 0.14 M NaCl. The urine was filtered
through the prepared diatomaceous earth layer, and
THPFU as a filtrate was obtained. To obtained the urinary THP, the diatomaceous earth with THP adsorbed
was washed with 100 ml PBS, scraped off and resuspended in water with stirring occasionally for 30 min-

Preparation of COM seeded crystals
COM crystals were prepared as described before
[5]: one liter of calcium chloride solution (0.25 M) was
added drop-wise to one liter of sodium oxalate solution
(0.25 M) over a period of 1 hour at room temperature.
The COM seed crystals produced were washed several
times with deionized water until no chloride ions were
detected. The COM seeded crystal suspension (24 mg/I)
was prepared and aged at 70°C for 2 hours with stirring. The prepared COM seeded crystals were kept at
room temperature at least for three weeks before use.
The COM seeded crystal has been characterized by Philips APD X-ray diffraction (Philips NV, Eindhoven,
Netherlands), and their spectrum completely agreed with
the spectra of commercial available COM.

Statistical methods
Determinations were performed in duplicate. A
statistical software package (STATGRAPHICS V6.0,
STSC, Inc., Rockville, MD) was chosen to perform the
Wilcoxon matched-pair signed-rank test (a non-parameter statistical test) and one-way analysis of variance to
compare the median values of each two groups.
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Figure 3. Changes in crystal number distributions in the presence and absence of an addition of G872 to an given
normal urine (No. 5): (a) initial distribution, (b) after 4 hours incubation without any additive, (c) with 2 % urine and
(d) with 2 % urine plus G872 (5 mg/I). The data for (b), (c) and (d) were collected from Coulter Multisizer II following
4 hours of COM seeded-crystal growth in a metastable solution.
Figure 4. Changes in crystal volume distributions in artificial urine: (a) initial distribution, (b) after 4 hours incubation
without any additive, (c) with 2 % urine and (d) with 2 % urine plus G872 (5 mg/I).

----------------------------------------------------------------------------------potential (ZP) in the urines from stone-formers (SF) and
non-stone formers (NSF). No significant difference of
urinary inhibitory activity was found between SF and
NSF. Only the median of ZP value is significantly higher in normal urine than in stone-forming urine (NS =
-21.4 ± 2.31 vs. NSF = -16.6 ± 2.53 mV; p < 0.05).

Results
G872 enhances urinary inhibitory activity and negative zeta potential values

Figure 2 shows a comparison of inhibitory activity
of crystal growth (IG) and agglomeration (IA), and zeta
405
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-29.6 mV respectively.

0

PUN

THPFU

UFU

0

Figure 6. Comparison of inhibitory activity against
crystal growth (IG) and agglomeration (IA), and the zeta
potential values (ZP) of a pooled normal urine (PNU)
with its derivatives such as THP-free urine (THPFU)
and ultrafiltered urine (UFU).

It was found that addition of 5 mg/I G872 to SF and
NSF urines significantly enhances the urinary inhibitory
activity against COM crystal growth and agglomeration
and the negative zeta potential values, suggesting a potential therapeutic efficacy of G872 in stone prevention.
In other words, exogenous sulphated polysaccharides,
e.g., G872, could be useful for stone prevention if such
compounds can appear unchanged in urine with a sufficient concentration following their (oral) administration.
The same amount of G872 added to the same volume of UFU (see Fig. 8, shown later) or to artificial
urine [7] shows a much higher inhibitory activity and
negative ZP, emphasizing the importance of the concept
of net-inhibitory activity again [29] .
As an example, Figures 3, 4 and 5 demonstrate the
effect of addition of G872 to a normal urine (No. 5) on
COM particle size distributions in number (Fig. 3) and
in volume (Fig. 4), and on zeta-potential distribution
(Fig. 5) of COM seed crystals. As observed in Figure
3, after 4 hours incubation the total crystal number and
portion of small crystal moiety are much higher in the
presence of G872 than in its absence. Moreover, the total volume and mean diameter of COM seeded crystals
are much less in the presence of G872 than in its absence (Fig. 4). The addition of G872 to this urine (No.
5) shifts the ZP distribution to more negative direction,
suggesting these COM seeded crystals can get a high
negative charge due to the adsorption of G872 to the
crystal surface (Fig. 5).
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Figure 7. Comparison of inhibitory activity (IA, IG) of
THP-free urine (THPFU) with its corresponding mimic
urines MU' 10, MU'S0 and MU'90. It should be noted
that THPFU and all mimic urines prepared have a similar composition (see text for details).
UFU, suggesting that UMS (MW > 5000 Da) mainly
account for urinary inhibitory activity. Although no differences of these parameters are found between PNU
and its corresponding THPFU, the role of THP on COM
crystallization cannot be ignored.

Different property of urinary macromolecular substance derived from between PNU and THPFU

Comparison of inhibitory activity and zeta potential
value of PNU to its derivatives (THPFU and UFU)

As compared with the original PNU, no significant
differences of inhibitory activity (IA and IG) were found
in the first series mimic urines (MUl0,50,90) prepared
by re-addition of UMSlO, UMS50 or UMS90 to the
UFU (not shown), whereas a much lower inhibitory
activity was found in the second series mimic urines

Figure 6 shows the parameters IG, IA and ZP from
pooled normal urine (PNU), THP-free urine (THPFU)
and ultrafiltered urine (UFU). It can be seen that the
inhibitory activity against crystal agglomeration and
growth and the negative ZP values are reduced in the
406
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0

Relative contributions of various urinary fractions to
total urinary inhibitory activity and negative zeta
potential
Figure 8 shows the inhibitory activities and negative
ZP values in ultrafiltered urine (UFU) and their reconstructed mimic urines, e.g., mixtures of UFU with CPC,
THP, THP + CPC and G872. As compared with PNU,
it is obvious that: (1) addition of G872 (5 mg/1) to UFU
showed the highest potency to increase IA, IG and ZP;
(2) re-addition of CPC is able to restore the parameters
to normal (PNU); and (3) re-addition of THP alone does
not restore inhibitory activity.

(MU' 10,50,90) prepared by addition of the THP-free
UMS'lO, UMS ' 50 and UMS'90 fractions to the UFU
(Fig. 7).
Interestingly, the inhibitory activity of these mimic
urines (MU'50 and MU'90) is much lower than those of
their original one: THPFU (Fig. 7) and PNU (Fig. 6).
When we assume that fractionation and recombination
compose a reversible reaction {eq. (5)}, the prepared
mimic urine obtained by mixing UFU and UMS 's at a
given UFU and UMS's ratio (1:9 for UMSlO, 5:5 for
UMS'50 and 9: 1 for UMS'90) should act similar as the
THPFU tested at the same concentrations.
THPFU.,. UFU + UMS'10(50,90)

UFU+
UFU+
CPC+THP G872

~

Discussion
In the past two decades, some important urinary
macromolecular inhibitors {e.g. , nephrocalcin [21], THP
[17), uropontin [31), GAGs [l], crystal matrix protein
(prothrombin activation peptide fragment 1) [33) and inter-a-trypsin protein [32]} have been isolated, purified
and identified. Some functional differences of these inhibitors such as THP and GAGs between SF and NSF
have also been reported [14, 17). In spite of these advances, however, we still do not completely understand
the role of these inhibitors in stone formation. For example, some urinary components have demonstrated a
strong inhibitory effect on both calcium oxalate and calcium phosphate crystallization in various model systems
in vitro [13, 22), to date, however, no systematic and
randomiz.ed clinical trails are found in literature to show

(5)

However, in the present study, the reconstituted urines
appear to inhibit less than the original urine. This
suggests that the reaction described in eq. (5) is an irreversible process. It is conceivable that the reduction of
inhibitory activity in the mimic urines (MU'50 and
MU'90) is due to denaturalization of the urinary macromolecular substances (UMS'50 and UMS'90) during
their preparation.
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decreasing the energy barrier. Both situation (b) and (c) will lead to particle agglomeration.
- - ---------------------------------------------------------------------------------------------

the significant differences of urinary inhibitory activity
between SF and NSF. In addition, although the dual effect of urinary inhibitors has been recognized [4, 14, 23,
29], little is known about the causes leading to low urinary inhibitory activity. The following open questions
are listed and are waiting to be answered in further
investigation:
(1) What is the molecular defect of urinary inhibitors in stone formers?
(2) How do the urinary inhibitors play a role in
pathogenesis of urolithiasis?
(3) Can the advances of inhibitor theory be used in
clinical practice for stone prevention?
Of course, these questions are very wide, and at this
moment we do not have sufficient knowledge to answer
all of them. An attempt was made in the present study
to illustrate the properties of urinary inhibitors and their
relative contributions to total urinary inhibitory activity.
The concept that human urine can be a protective
colloidal system was first put forward by Butt in 1952
[3]. For many reasons, considering the human urine as
a colloid system would be better than considering it a
simple solution. Maintaining the stability of urinary colloidal system could be an efficient approach to stone

prevention. Zeta potential, as a very sensitive marker,
has been chosen to study the stability of the urinary colloidal system and the mechanisms of crystal agglomeration [2, 5, 8, 16, 17, 28]. In the present study, the
method of ZP measurement has been modified and used
successfully. As compared with previous ZP measurement [28], the new method described in this paper enables us to eliminate the interference of urinary pH and
ionic strength with ZP measurement. Moreover, the
new ZP measurement could be further used to study the
interactions between two crystals coated by the same
and/or different macromolecules in a given medium
which could be useful for a better understanding of the
mechanisms of inhibition by urinary macromolecules inhibitors in COM crystallization, especially concerning
COM crystal agglomeration.
In this study, a significant difference of negative ZP
values was found between stone-formers and non-stoneformers (Fig. 2). Moreover, it was observed that addition of G872 to SF and NSF urines significantly increases in the negative ZP values (Figs. 2 and 5). Readdition of CPC to UFU completely restored the urinary
inhibitory activity (Fig. 8). These findings indicate that
there is a highly negative charge density on the COM
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Figure 10. A schematic diagram of binding modes of urinary macromolecular substances (UMS) on COM crystal surface and corresponding changes of Gibbs free energy (G): a loosely structural layer formed by adsorption of UMS,
which leads to a significant increase of total energy (steric hindrance) (a and b); a compact structural layer formed by
adsorption of UMS, which leads to a significant decrease of total free energy (steric bridging) (c and d). G: surface
free energy; G 8 : van der Waals attraction; Ge: electrostatic repulsion; Gb: steric hindrance or steric bridging energy;
and G1: total energy.
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crystals following the adsorption of CPC. The same
could be observed after G872 addition to UFU. The
more negative the mean ZP value at the interface between COM crystals and surrounding solution, the higher the dispersion of the COM crystals, which was indeed
shown by the particle si:ze analysis (Figs. 3 and 4).
However, we did not find any significant difference
in the ZP values between PNU and THPFU and its
mimic urines such as MU' 10,50,90 (not shown), irrespective of the big differences in inhibitory activity between them (Fig. 7). This finding suggested that there
could be a different binding property between the urinary macromolecular substances in the THPFU and in
its mimic urines. It also shows that inhibitory potential
and ZP are two different entities which act and are influenced independently of each other.
To explain the phenomena, it is necessary to mention the interaction between two separated particles
which has been described by Finlayson [11] and Robertson [29] {see eq. (6)}:

(6)
where VT: the total interaction potential between two
particles; VA: van der Waals attraction; VR: electrostatic
repulsion; and Vy: viscous binding. In general, both
DLVO (Derjaguin, Landau, Verwey and Overbeek) interaction (Fig. 9) [19] and steric interaction (Fig. 10)
[12] can be taken to understand the stability of urinary
colloidal system as well as the mechanism of crystal agglomeration. From Figure 9, it can be imagined that increase of ionic strength or reduction of surface charge
compress the double layer resulting in decreasing of the
energy barrier which may benefit for crystal agglomeration. In our case, G872 and CPC with high negative
charge bound to COM crystal surfaces may enhance
electrostatic repulsion leading to crystal agglomeration
prevention. Moreover, it is also necessary to emphasi:ze
that the viscous binding may contribute to the total
interaction potential by the steric effect, resulting in
promotion of either crystal dispersion by steric hindrance
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ally to around 1 %), different inhibitors are diluted to
varying extents, and the resulting overall activity may
bear no relation to the inhibitory effect that the urine
may have on CaOx crystallization in the undiluted state.
These difficulties, perhaps, concern study on methodological standardization. In our opinion, the main
problem of this model is how to record and evaluate
the extra fine particles and extra large particles. The
former has gone beyond the detection range of Coulter Counter single tube technique and the latter may
related to additional foreign catalytic surface. Both
extra fine and large particles may associated with the
possibility of second nucleation, de-agglomeration of
poly-crystals and additional foreign catalytic surface.
For instance, a potential secondary nucleation induced
by adding G872 to human urine, as pointed out by Dr.
Nancollas, could not be detected with the single tube
technique of Coulter Counter.

Disc~ion with Reviewers

R.L. Ryall: The methodology used to assess inhibitory
activity is of great concern. This technique was published about 14 years ago, and we have since published
work demonstrating its inability to quantify inhibitory
activity accurately. One concern is that crystal growth
and aggregation are not fully independent processes;
because the amount of CaOx deposited during the reaction is dependent upon the available surface area, crystal
growth expressed as increasing volume will depend upon
the degree of aggregation of the crystals. A second
worry is that the lower limit of detection of the Coulter
Counter excludes many crystals from being recorded by
the instrument and this can introduce large errors in the
calculation of inhibitory activity. These problems can
only be addressed by use of a computer model to obtain
accurate estimates of inhibitory activity [39]. Our work
has been extended by Dr. Michael Hounslow of the Department of Chemical Engineering, University of Cambridge. A non-iterative computer model has been available for analyzing Coulter Counter data obtained from
reaction involving simultaneous CaOx crystal growth and
aggregation [38]. For this reason, the data related to inhibitory activity measurements are invalid and therefore,
should not be used.
G.H. Nancollas: The finding that the addition of G872
produces more small crystallites (lower crystal volume
and diameter) with greater zeta potential, may suggest
secondary nucleation processes at surfaces on which the
additive molecules have been immobilized.
H.G. Tiselius: The effects on the inhibition of crystal
growth and crystal aggregation was measured by its reflection in the zeta potential as well as by data derived
from size distribution in a Coulter Counter. Of these
two methods, the zeta potential is probably most significant because the accuracy of this technique is probably
greater than that of crystal size analysis.
Authors: Although the weakness or limitation existing
in the Coulter Counter model has long been recognized
by many investigators including ourselves, the model as
a tool in stone research is still used in many laboratories. We are impressed by Dr. Ryall's special contribution to the model and believe that the principle of the
model is correct and the existing problems in this model
are common as compared with other crystallization model systems in vitro. In our own experience, the currently used Coulter Counter model looks good for evaluation of inhibitory activity of single and pure inhibitors
such as GAGs and the results can be compared with
Constant Composition model. But, for a complex sample such as human urine, the model may sometimes have
deficiencies because urine composition cannot be controlled. Moreover, because they have to be diluted (usu-

R.L. Ryall: I firmly believe that the model you used,
and which you point out, we have used ourselves, has
much to offer stone research. However, there are two
factors that need to be taken into account: (a) Coulter
Counter data need to be corrected to take account of the
deficiencies I have listed. (b) Data must not be used to
draw conclusions about an inhibitor's possible action in
urine in vivo. In addition, even you find that the model
"looks good for evaluation of inhibitory activity of a
single and pure inhibitors such as GAGs," I can only
stress, once again, that the data are only useful to draw
conclusions about an inhibitor's action in an inorganic
solution. For example, chondroitin is a powerful inhibitor of aggregation in a seeded, inorganic metastable solution, but it has no material effect in urine and this is
perfectly in keeping with its absence from both CaOx
stone and crystals. Could you explain in detail the real
difference between aggregation and agglomeration? The
term "agglomeration" has crept into stone research in recent years with no author ever bothering to explain its
meamng.
Authors: We agree with your principle mentioned in
(a) and (b), and are glad to hear that Drs. Hounslow and
Bramley of the University of Cambridge are willing to
help us in improving our current model. However, we
think that any results from any in vitro crystallization
model systems used currently may not completely represent the situations in whole urine and in vivo. Your example about the absence of chondroitin in stone matrix
and crystal matrix does not exclude the role of chondroitin in stone formation. More recent evidence [40] has
demonstrated the difference of chondroitin between
stone-formers and non-stone-formers. Considering a
change of available surface area of seeded crystals induced by crystal flocculation or coagulation, which may
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macromolecules of interest. In the ZP measurements,
the COM crystal were re-suspended in diluted artificial
urine. This contains considerable concentrations of
phosphate ion and it is quite possible that other phases
(e.g., calcium phosphates) will precipitate on the crystal
surface. Did the authors do energy-dispersive X-ray
(EDX) measurements in order to verify that this did not
occur?
R.L. Ryall: Why were the zeta potential measurements
made in artificial urine and not measured directly in the
urine samples, which would more accurately reflect
physiological conditions?
Authors: Although it is not difficult to measure directly
the ZP of COM crystals in whole urine, the results from
such whole urine could be difficult to evaluate due to
undefined pH, ionic strength and other reasons. The
new approach of the ZP measurement presented in this
paper may overcome the above difficulties. After incubation of COM crystals in whole urine, the COM crystals coated by urinary macromolecules have all original
feature of these compounds and the results from re-suspending COM in artificial urine can fully reflect the
characteristics of urinary macromolecules. The precipitation of calcium phosphate on COM could occur in resuspension process as pointed out by Dr. Nancollas,
therefore, the suggested EDX measurements should be
done later.

have an influence on crystal growth, it could be necessary to define the terms of aggregation and agglomeration. Nancollas [22] stated: "The terms flocculation and
coagulation refer to the tendency for small suspended
particles in a liquid to form aggregates or agglomerates.
Aggregates may be regarded as groups of primary particles joined at their faces and having surface areas significantly less than the sum of the areas of their constituent
particles. In agglomeration, the primary particles may
be regarded as being joined at edges and comers so that
the surface area of the resulting particles is not markedly
different from the sum of the areas of the individual
components." We suppose that agglomeration could be
a main manner of crystal flocculation in the used Coulter
Counter model.

S.R. Khan: Why is there so little difference in inhibition and agglomeration between the normals and the
stone formers, and yet the ZP is much lower for the
stone formers?
R.L. Ryall: For the data presented in Figure 2, all
urines were centrifuged at 1500 x g for 10 minutes and
were also frozen at -20°C. It is known that such treatment may cause the loss of substantial amounts of THP
[35] and induce precipitation of urinary proteins and
CaOx crystal [37) . Did the authors check the effects of
their urine treatment procedures on THP and total protein and GAG concentrations? What steps were taken to
ensure after thawing that precipitated macromolecules
and crystals were completely redissolved? Were the effect of freezing and thawing on ZP and inhibitory activity measurements checked?
Authors: We do not know why no significant difference of urinary inhibitory activity was found in this
study between stone patients and normals. Too small
sample count (n = 10 for each) could be one of the reasons because we found a significant difference of these
parameters in our previous investigation [34]. A second
reason could be related to treatment and store of the
urine samples which we shall seriously consider checking the influence of urinary pretreatment on the results
of urinary inhibitory activity and ZP. It may be necessary to mention that only 5 ml urine for each individual
samples underwent such treatment, because we were
pressed for time. The pooled urine and various urinary
fractions were prepared without centrifuging and
freezing stone procedures.

H.G. Tiselius: From a therapeutic/prophylactic point of
view, the effects of G872 appear promising and the effects on the ZP are obviously reflected in corresponding
changes in the crystal size distribution. In these experiments, G872 was added to give a final concentration of
5 mg/l. Is it likely that this concentration can be attained in urine following an oral load of this preparation?
Authors: Little is known about metabolism of endogenous GAGs as well as exogenous sulfated polysaccharides, such as, G872. The final concentration of 5 mg/l
was chosen according to the pharmacokinetic study of
SP54 [36]. The results from in vitro models suggest potential use of G872 for stone prevention, however, the
actual situations concerning the role of G872 in stoneforming rats and human urolithiasis are much complex.
Up to now, we could not measure the precise amount of
urinary G872 following an oral load. Moreover, we
could not find a significant increase of total GAGs excretion as well as of urinary inhibitory activity in stoneforming rats induced with ethylene glycol and vitamin
D 3 following oral G872 administration. However, a
preliminary clinical study demonstrated a significant increase of urinary GAGs excretion following oral G872
administration (200 mg/day). This may suggest a different metabolic response to G872 between humans and rats.

G.H. Nancollas: The zeta potential is an extremely
sensitive parameter for measuring changes in surface
charge. In order to make proper comparisons, the isoelectric point is more useful. The authors should make
ZP measurements as a function of pH on both the COM
pure surfaces and those which have been coated with the
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Additional References

S.R. Khan: Why are the normal urines pooled and not
the stone former urines?
R.L. Ryall: I am afraid that I still cannot agree with
your statement about the protective effect of THP on urinary macromolecular inhibitors, because you did not
perform any experiments to examine molecular defects
of urinary inhibitors.
Authors: Indeed, in the present study no special attempt was made to identify the difference of urinary inhibitors between SF and NSF. However, an irreversible
process was found in THPFU {see eq. (5) and corresponding text for details}, but was not in PNU which
prompted us to make the speculation about protective
effect of THP.
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R.L. Ryall: The procedure you use for removing THP
is very good. However, I must ask you whether you are
certain whether the diatomaceous earth procedure you
use removes only THP. Are you certain that all the
other macromolecules are not removed?
Authors: The result from ELISA [2] suggest that all
urinary THP can be removed from original urine using
the diatomaceous earth procedure. But, we are not sure
whether other urinary macromolecules are also removed.
This point needs to be investigated further.
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